BEAM
Price
$22.72
Change
+$0.98 (+4.51%)
Updated
May 2, 6:59 PM EST
4 days until earnings call
CRBU
Price
$3.64
Change
-$0.05 (-1.36%)
Updated
May 2, 6:59 PM EST
4 days until earnings call
Ad is loading...

Analysis and predictions BEAM vs CRBU

Header iconBEAM vs CRBU Comparison
Open Charts BEAM vs CRBUBanner chart's image
Beam Therapeutics
Price$22.72
Change+$0.98 (+4.51%)
Volume$608.97K
CapitalizationN/A
Caribou Biosciences
Price$3.64
Change-$0.05 (-1.36%)
Volume$1.5M
CapitalizationN/A
View a ticker or compare two or three
BEAM vs CRBU Comparison Chart

Loading...

BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
CRBUDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BEAM vs. CRBU commentary
May 03, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and CRBU is a Hold.

COMPARISON
Comparison
May 03, 2024
Stock price -- (BEAM: $22.72 vs. CRBU: $3.64)
Brand notoriety: BEAM and CRBU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 71% vs. CRBU: 137%
Market capitalization -- BEAM: $1.87B vs. CRBU: $328.76M
BEAM [@Biotechnology] is valued at $1.87B. CRBU’s [@Biotechnology] market capitalization is $328.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $559.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.61B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileCRBU’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • CRBU’s FA Score: 1 green, 4 red.
According to our system of comparison, CRBU is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while CRBU’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 4 bearish.
  • CRBU’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than CRBU.

Price Growth

BEAM (@Biotechnology) experienced а +5.19% price change this week, while CRBU (@Biotechnology) price change was -3.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.22%. For the same industry, the average monthly price growth was -1.75%, and the average quarterly price growth was +1238.84%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 06, 2024.

CRBU is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (+5.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BEAM with price predictions.
OPEN
A.I.dvisor published
a Summary for CRBU with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BEAM($1.87B) has a higher market cap than CRBU($329M). BEAM YTD gains are higher at: -16.532 vs. CRBU (-36.475).
BEAMCRBUBEAM / CRBU
Capitalization1.87B329M569%
EBITDAN/AN/A-
Gain YTD-16.532-36.47545%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
BEAMCRBU
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
CRBUDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RISAX22.710.34
+1.52%
Manning & Napier Rainier Intl Discv S
CSGTX4.840.07
+1.47%
Transamerica Small Cap Growth C
LGLAX36.540.51
+1.42%
Lord Abbett Growth Leaders A
SPGIX40.750.43
+1.07%
SEI Large Cap Growth I (SIMT)
FERRX10.640.07
+0.66%
First Eagle Global Real Assets R6

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with AXON. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-1.36%
AXON - CRBU
50%
Loosely correlated
+1.66%
NTLA - CRBU
46%
Loosely correlated
+3.42%
ORMP - CRBU
45%
Loosely correlated
N/A
EDIT - CRBU
42%
Loosely correlated
+2.74%
BEAM - CRBU
40%
Loosely correlated
+4.51%
More